Tag: Pfizer
Pfizer’s LORBRENA achieves 60% five-year survival in ALK-positive lung cancer
Phase 3 CROWN trial shows 81% reduction in progression risk and 94% fewer brain metastases compared to XALKORI®
GSK’s Arexvy label expansion will intensify competition with Pfizer’s Abrysvo in...
The European Medicines Agency (EMA) recently accepted the company’s regulatory application to expand the use of Arexvy and a decision is anticipated in H2 2024
KIMS Hospitals and Pfizer collaborate to unveil CoE for Adult Vaccination...
Through this CoE, KIMs and Pfizer want to make a substantial contribution to respiratory health in Hyderabad and Telangana, aligning with the broader national and global efforts to combat the rising impact of infectious diseases and respiratory illnesses
Alnylam patent lawsuit against Pfizer, Moderna highlights escalating legal pressure on...
The potential for lucrative settlements in the multi-billion-dollar COVID-19 vaccine market adds further significance to these legal battles
Pfizer acquires Seagen for US$ 43 billion to develop better cancer...
Proposed combination enhances Pfizer’s position as a leading company in oncology
Pfizer initiates Phase 3 Study of mRNA-based Influenza vaccine
First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older
Pfizer launches its 6th helpdesk in cancer hospitals
Health Minister of Chhattisgarh, T. Singh Deo inaugurates Project Aastha Helpdesk to aid cancer patients during diagnosis, treatment, and rehabilitation
Pfizer’s support to Tata Trusts cancer care programme helps screen close...
Under the programme, health and wellness NCD screening kiosks have been set up in 4 hospitals. Virtual patient helpdesk engaged with over 50,000 patients
Pradip Shah appointed as Chairman of Pfizer’s Board
Mr. Pradip Shah succeeds Mr. R A Shah who stepped down as Chairman
Pfizer supports deployment of 400 oxygen beds in Delhi
The company has also supported ICU beds in Mumbai COVID care facilities and provided additional supply of essential COVID medicines valued at over Rs. 510-crore mobilized for government hospitals.......................